Biotin-responsive basal ganglia disease: a novel entity.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Brain : a journal of neurology

• Publication date

  1998-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/BRAIN/121.7.1267PMID 9679779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of biotinidase activity with biotinyl-6-aminoquinoline as substrate.

  1997cited by this paper
• Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance.

  1996cited by this paper
• [A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].

  1996cited by this paper
• Diagnosis of Inborn Errors of Metabolism from Blood Spots by Acylcarnitines and Amino Acids Profiling Using Automated Electrospray Tandem Mass Spectrometry

  1995cited by this paper
• An atypical French form of pyruvate carboxylase deficiency.

  1995cited by this paper
• CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients.

  1995cited by this paper
• Electrospray tandem mass spectrometry in the diagnosis of organic acidemias

  1994cited by this paper
• CT and MR of the brain in the diagnosis of organic acidemias. Experiences from 107 patients.

  1994cited by this paper
• Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder.

  1994cited by this paper
• MRI, Clinical, and Biochemical Features of Partial Pyruvate Carboxylase Deficiency

  1994cited by this paper
• The clinical spectrum of biotin-treatable encephalopathies in Saudi Arabia.

  1994cited by this paper
• Extrapyramidal disorders in childhood.

  1993influential reference
• Reversal of brain atrophy with biotin treatment in biotinidase deficiency.

  1993cited by this paper
• Hallervorden-Spatz disease: MR and pathologic findings.

  1993cited by this paper
• Childhood stroke associated with protein C or S deficiency and primary antiphospholipid syndrome.

  1993cited by this paper
• Bilateral striatal lesions in childhood.

  1993influential reference
• Abnormal MRI signal in the rigid form of Huntington's disease.

  1991cited by this paper
• Dopa‐responsive dystonia

  1991cited by this paper
• Infantile bilateral striatal necrosis.

  1991cited by this paper
• Prevalence of different types of lysosomal storage diseases in saudi arabia

  1990cited by this paper
• Acute neurologic dysfunction associated with destructive lesions of the basal ganglia: a benign form of infantile bilateral striatal necrosis.

  1990influential reference
• Partial cytochrome b deficiency and generalized dystonia.

  1990cited by this paper
• Ischaemic stroke in the basal ganglia and internal capsule in childhood.

  1989cited by this paper
• Postinfectious encephalomyelitis with localized basal ganglia involvement.

  1989cited by this paper
• Bilateral Striatal Lesions

  1988cited by this paper
• Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.

  1987cited by this paper
• Biotin Transport Through the Blood‐Brain Barrier

  1987influential reference
• Movement disorders in bacterial meningitis.

  1986cited by this paper
• A case report of infantile striatal necrosis with an acute onset.

  1986cited by this paper
• Biotinidase deficiency

  1986cited by this paper
• Bilateral lucency of the globus pallidus complicating methylmalonic acidemia

  1986cited by this paper
• Infantile bilateral striatal necrosis. Clinicopathological classification.

  1986cited by this paper
• Holes in the Brain

  1985cited by this paper
• Holes in the brain.

  1985cited by this paper
• Biotinidase deficiency: Initial clinical features and rapid diagnosis

  1985cited by this paper
• Neurologic symptoms of biotinidase deficiency

  1985cited by this paper
• Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome

  1984cited by this paper
• Leigh's necrotizing encephalopathy with pyruvate carboxylase deficiency.

  1983cited by this paper
• Acute neurological dysfunction associated with destructive lesions of the basal ganglia in children

  1982cited by this paper
• The biotin-dependent carboxylase deficiencies.

  1982cited by this paper
• [Encephalitis of the basel ganglia associated with mumps].

  1982cited by this paper
• Mutant holocarboxylase synthetase: evidence for the enzyme defect in early infantile biotin-responsive multiple carboxylase deficiency.

  1981cited by this paper
• Biotin-response organicaciduria. Multiple carboxylase defects and complementation studies with propionicacidemia in cultured fibroblasts.

  1979cited by this paper
• Striatal degeneration in childhood.

  1979cited by this paper
• Propionyl-CoA Carboxylase Deficiency in a Patient with Biotin-responsive 3-Methylcrotonylglycinuria

  1977cited by this paper
• Idiopathic torsion dystonia (dystonia musculorum deformans). A review of forty-two patients.

  1974cited by this paper
• Juvenile parkinsonism.

  1971influential reference
• The biotin-dependent enzymes.

  1971cited by this paper
• AVIDIN. 1. THE USE OF (14-C)BIOTIN FOR KINETIC STUDIES AND FOR ASSAY.

  1963cited by this paper

• Region-specific brain structural modulation and amyloid-β pathology associated with dietary biotin: insights into dementia neuropathology.

  2026cites this paper
• Inherited disorders of vitamin metabolism.

  2025cites this paper
• Dopamine Transporter Deficiency Syndrome: A Rare Case of Infantile-Onset Dystonia-Parkinsonism

  2025cites this paper
• Biological properties of vitamins of the B-complex, part 2 - vitamins B6 and B7 (biotin, vitamin H).

  2025cites this paper
• Case Report: Unusual Neurological Features of Leigh Syndrome due to m.8993T>G Pathogenic Variant in the MT‐ATP6 Gene

  2025cites this paper
• Vitamin Bs as Potent Anticancer Agents through MMP-2/9 Regulation.

  2025cites this paper
• Rare Movement Disorders—An Approach for Clinicians

  2025cites this paper
• Biotin-Thiamine-Responsive Basal Ganglia Disease: Clinical Features, Treatment Response and Predictive Factors in a Cohort in a Tertiary Hospital

  2025cites this paper
• Acute Necrotizing Encephalopathy in a Child With RANBP2 Mutation: A Case of Unanticipated Full Resolution

  2025cites this paper
• Structural basis of thiamine transport and drug recognition by SLC19A3

  2024cites this paper
• Precision diagnosis and treatment of vitamin metabolism-related epilepsy

  2024cites this paper
• Report of a novel recurrent homozygous variant c.620A>T in three unrelated families with thiamine metabolism dysfunction syndrome 5 and review of literature

  2024cites this paper
• Biotin Homeostasis and Human Disorders: Recent Findings and Perspectives

  2024cites this paper
• Structural basis of substrate transport and drug recognition by the human thiamine transporter SLC19A3

  2024cites this paper
• Mitochondrial disorder diagnosis and management- what the pediatric neurologist wants to know.

  2024cites this paper
• Efficacy of high thiamine dosage in treating patients with biotin thiamine responsive basal ganglia disease: a two case reports

  2024cites this paper
• Vitamin B1 deficiency leads to high oxidative stress and mtDNA depletion caused by SLC19A3 mutation in consanguineous family with Leigh syndrome

  2023cites this paper
• SLC25A19 Mutation-Related Bilateral Striatal Necrosis and Limbic System Involvement: A Case Report and Review of the Literature

  2023cites this paper
• Vitamin B1 de�ciency leads to high oxidative stress and mtDNA depletion caused by SLC19A3 mutation in consanguineous family with Leigh syndrome

  2023cites this paper
• Developing of Biotin-Thiamine Responsive Basal Ganglia Disease after Accidental Ingestion of Ethyl Alcohol: A Case Report

  2023cites this paper
• Mechanisms underlying phenotypic variation in neurogenetic disorders

  2023cites this paper
• Thiamine deficiency in pregnancy and lactation: implications and present perspectives

  2023cites this paper
• Biotin-thiamine responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of cases in Kuwait with novel variants

  2023cites this paper
• Rare Case of Biotin-Thiamine-Responsive Basal Ganglia Disease Presenting in a Neonate

  2022cites this paper
• Thiamine Disorders

  2022cites this paper
• Case Report: Motor and Sensory Development of a Case Followed with Suspicion of Neonatal Thiamine Metabolism Dysfunction Syndrome

  2022cites this paper
• Beyond the caudate nucleus: Early atypical neuroimaging findings in biotin-thiamine- responsive basal ganglia disease.

  2022cites this paper
• Case report: biotin-thiamine-responsive basal ganglia disease with severe subdural hematoma on magnetic resonance imaging

  2022cites this paper
• Biotin-Responsive Basal Ganglia Disease: Treatable Metabolic Disorder with SLC19A3 Mutation Presenting as Rapidly Progressive Dementia

  2022cites this paper
• Effects Of Biotin Deficiency On Short Term Memory: The Role Of Glutamate, Glutamic Acid, Dopamine And Protein Kinase A.

  2022cites this paper
• Biotin-thiamine-responsive basal ganglia disease: A case report

  2021cites this paper
• Reduced Thiamine Availability and Hyperglycemia Impair Thiamine Transport in Renal Glomerular Cells through Modulation of Thiamine Transporter 2

  2021cites this paper
• Biotin-Thiamine-Responsive Basal Ganglia Disease in Children: A Treatable Neurometabolic Disorder

  2021cites this paper
• Thiamine and diabetes: back to the future?

  2021cites this paper
• Report of the Largest Chinese Cohort With SLC19A3 Gene Defect and Literature Review

  2021cites this paper
• Early Infantile Thiamine Transporter-2 Deficiency with Epileptic Spasms—A Phenotypic Spectrum with a Novel Mutation

  2021cites this paper
• Early treatment of biotin–thiamine–responsive basal ganglia disease improves the prognosis

  2021cites this paper
• SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population

  2021cites this paper
• Biotin-thiamine responsive basal ganglia disease in the era of COVID-19 outbreak diagnosis not to be missed: A case report

  2021cites this paper
• Multivitamin (Thiamine) Responsive Basal Ganglia Disease Mimicking Acute Encephalitis Syndrome among Infants of Bodo Tribe Assam: A Retrospective Study

  2021cites this paper
• Movement Disorders and Inherited Metabolic Disorders

  2020cites this paper
• Biotin-Responsive Basal Ganglia Disease: EEG Characteristics and Seizure Phenotypes

  2020cites this paper
• Eleven novel mutations and clinical characteristics in seven Chinese patients with thiamine metabolism dysfunction syndrome.

  2020cites this paper
• Treatable Movement Disorders of Infancy and Early Childhood

  2020cites this paper
• Biotin

  2020cites this paper
• Single gene, two diseases, and multiple clinical presentations: Biotin-thiamine-responsive basal ganglia disease.

  2020cites this paper
• Biotin–Thiamine Responsive Basal Ganglia Disease Presented as Intractable Seizure in a 1-Month-Old Infant

  2020cites this paper
• High‐dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy

  2020cites this paper
• Biotin

  2019cites this paper
• Targeted SLC19A3 gene sequencing of 3000 Saudi newborn: a pilot study toward newborn screening

  2019cites this paper
• Identification of Genetic Copy Number Variants in Neurodevelopmental Disorders from Genome Sequence Data

  2019influential citation
• Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy

  2019cites this paper
• Movement Disorders in Treatable Inborn Errors of Metabolism

  2019cites this paper
• Bilateral Striatal Necrosis with Polyneuropathy with a Novel SLC25A19 (Mitochondrial Thiamine Pyrophosphate Carrier OMIMI*606521) Mutation: Treatable Thiamine Metabolic Disorder—A Report of Two Indian Cases

  2019cites this paper
• Biotin in metabolism, gene expression, and human disease

  2019cites this paper
• Methods for assessment of biotin (Vitamin B7)

  2019cites this paper
• [Paroxysmal crying and motor regression for more than two months in an infant].

  2019cites this paper
• Neuroimaging Findings in Primary Mitochondrial Cytopathies

  2019cites this paper
• Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies

  2019cites this paper
• Spinozerebelläre Ataxien und hereditäre spastische Paraplegien bei Kindern und Jugendlichen

  2019cites this paper
• Eye movement disorders and neurological symptoms in late‐onset inborn errors of metabolism

  2018cites this paper
• Biotin-Thiamine-Responsive Basal Ganglia Disease: Case Report and Follow-Up of a Patient With Poor Compliance

  2018cites this paper
• Neuroimaging of Mitochondrial Cytopathies

  2018cites this paper
• Biotin–Thiamine Responsive Basal Ganglia Disease: A Treatable Metabolic Encephalopathy—Not to Be Missed!

  2018cites this paper
• Biotin-Thiamine-Responsive Basal Ganglia Disease-A Treatable Metabolic Disorder.

  2018cites this paper
• Biotin Thiamin Responsive Basal Ganglia Disease in Siblings

  2018cites this paper
• Infantile neuroaxonale Dystrophie Seitelberger und Cockayne-Syndrom

  2018cites this paper
• Biotin-Thiamine Responsive Encephalopathy: Report of an Egyptian Family with a Novel SLC19A3 Mutation and Review of the Literature

  2018cites this paper
• Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease?

  2018cites this paper
• Compound heterozygous SLC19A3 mutations further refine the critical promoter region for biotin-thiamine-responsive basal ganglia disease

  2017influential citation
• TPK1 mutation induced childhood onset idiopathic generalized dystonia: Report of a rare mutation and effect of deep brain stimulation.

  2017cites this paper
• Case 38-2017. A 20-Year-Old Woman with Seizures and Progressive Dystonia.

  2017cites this paper
• High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice

  2017cites this paper
• Biotin‐thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next‐generation sequencing data

  2017influential citation
• Phenotype-genotype correlations in Leigh syndrome: new insights from a multicentre study of 96 patients

  2017cites this paper
• SLC19A3 Gene Defects Sorting the Phenotype and Acronyms: Review

  2017cites this paper
• Psychological Assessment of Patients With Biotin-Thiamine-Responsive Basal Ganglia Disease

  2017cites this paper
• Early Infantile Leigh-like SLC19A3 Gene Defects Have a Poor Prognosis: Report and Review

  2017cites this paper
• Movement Disorders in Children

  2017cites this paper
• Disorders of vitamins and cofactors

  2017cites this paper
• Thiamine deficiency in childhood with attention to genetic causes: Survival and outcome predictors

  2017cites this paper
• Neuropathological characteristics of the brain in two patients with SLC19A3 mutations related to the biotin-thiamine-responsive basal ganglia disease.

  2017cites this paper
• Biotin–thiamine–responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment

  2017cites this paper
• Biotin: From Nutrition to Therapeutics.

  2017cites this paper
• Treatable mitochondrial diseases: cofactor metabolism and beyond.

  2017cites this paper
• A case report of biotin–thiamine-responsive basal ganglia disease in a Saudi child

  2016cites this paper
• Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis

  2016cites this paper
• Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach

  2016cites this paper
• Treatment of genetic defects of thiamine transport and metabolism

  2016cites this paper
• Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis.

  2016cites this paper
• Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis

  2016cites this paper
• Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy

  2016cites this paper
• Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome.

  2016cites this paper
• Depression in adult patients with biotin responsive basal ganglia disease.

  2016cites this paper
• Mutations in SLC5A6 associated with brain, immune, bone, and intestinal dysfunction in a young child

  2016cites this paper
• Treatable Inborn Errors of Metabolism Due to Membrane Vitamin Transporters Deficiency.

  2016cites this paper
• Treatable Inborn Errors of Metabolism Due to Membrane Vitamin Transporters Deficiency

  2016cites this paper
• Selective accumulation of biotin in arterial chemoreceptors: requirement for carotid body exocytotic dopamine secretion

  2016cites this paper
• Amenable Treatable Severe Pediatric Epilepsies.

  2016cites this paper
• Klinička raznolikost bolesti uzrokovane nasljednim mutacijama gena za prijenosnik tiamina-2 (ThTr2)

  2015cites this paper